126 related articles for article (PubMed ID: 1297107)
1. A comparison of antihypertensive properties of captopril and enalapril after single and multiple oral administration in spontaneously hypertensive rats.
Kosmala M; Oledzka K; Lewandowski K; Filczewski M; Miłobedzka J
Pol J Pharmacol Pharm; 1992; 44(5):437-42. PubMed ID: 1297107
[TBL] [Abstract][Full Text] [Related]
2. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
Tanaka M; Yamamoto S; Nakao K; Inukai T; Ogawa N; Katsumura H; Ohara N; Shukunobe K; Ono H
Arzneimittelforschung; 1991 Jun; 41(6):608-12. PubMed ID: 1930348
[TBL] [Abstract][Full Text] [Related]
4. Suppression of hypotensive responses of captopril and enalapril by the kallikrein inhibitor aprotinin in spontaneously hypertensive rats.
Sharma JN; Amrah SS; Noor AR
Pharmacology; 1995 Jun; 50(6):363-9. PubMed ID: 7568335
[TBL] [Abstract][Full Text] [Related]
5. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
8. Influence of coenzyme Q-10 on the hypotensive effects of enalapril and nitrendipine in spontaneously hypertensive rats.
Danysz A; Oledzka K; Bukowska-Kiliszek M
Pol J Pharmacol; 1994; 46(5):457-61. PubMed ID: 7894534
[TBL] [Abstract][Full Text] [Related]
9. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats.
Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT
Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the efficacy of captopril and enalapril in single doses in the treatment of arterial hypertension. Evaluation by means of non-invasive ambulatory monitoring].
Valori C; Gambini G; Canini F; Marinelli M; Rossi S; Pinchi G
Clin Ter; 1989 Jul; 130(1):37-44. PubMed ID: 2551565
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic effect of captopril and enalapril in young rats.
Buczko W; Kubik A; Kucharewicz I; Chabielska E
Pol J Pharmacol; 2004; 56(1):97-104. PubMed ID: 15047983
[TBL] [Abstract][Full Text] [Related]
13. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
Sabino B; Lessa MA; Nascimento AR; Rodrigues CA; Henriques Md; Garzoni LR; Levy BI; Tibiriçá E
J Cardiovasc Pharmacol; 2008 Apr; 51(4):402-9. PubMed ID: 18427284
[TBL] [Abstract][Full Text] [Related]
14. Effects of antihypertensive agents on blood pressure and the progress of renal failure in partially nephrectomized spontaneously hypertensive rats.
Katsumata H; Suzuki H; Ohishi A; Nakamoto H; Saruta T; Sakaguchi H
Lab Invest; 1990 Apr; 62(4):474-80. PubMed ID: 2185377
[TBL] [Abstract][Full Text] [Related]
15. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Yaoka O; Aoki K; Nakajima T; Setoguchi M
Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
[TBL] [Abstract][Full Text] [Related]
18. Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.
Berecek KH; Nagahama S; Oparil S
J Hypertens Suppl; 1984 Dec; 2(3):S63-6. PubMed ID: 6100756
[TBL] [Abstract][Full Text] [Related]
19. Cardiac mitochondrial function and tissue remodelling are improved by a non-antihypertensive dose of enalapril in spontaneously hypertensive rats.
Piotrkowski B; Koch OR; De Cavanagh EM; Fraga CG
Free Radic Res; 2009 Apr; 43(4):390-9. PubMed ID: 19296328
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue.
Hamilton TC; Howlett DR; Longman SD; Markwell RE; Norton J; Summers DR; Wilson C
Arzneimittelforschung; 1988 Apr; 38(4):531-6. PubMed ID: 2840917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
